Screener
Artiva Biotherapeutics, Inc. ARTV Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
| PERIOD ENDED JUNE 30, | |
|---|---|
| 2027 | 3,497 |
| 2028 | 3,603 |
| 2029 | 2,284 |
| Total minimum lease payments | 11,090 |
| Less: amount representing interest | (1,241) |
| Present value of operating lease liabilities | 9,849 |
| Less: operating lease liabilities, current | (3,299) |
| Operating lease liabilities, net of current portion | $6,550 |
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s operating lease liabilities (total)?
- Artiva Biotherapeutics, Inc. (ARTV) reported operating lease liabilities (total) of $9.85M in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s operating lease liabilities (total) changed year-over-year?
- Artiva Biotherapeutics, Inc.'s operating lease liabilities (total) decreased by 24.9% year-over-year, from $13.12M to $9.85M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Artiva Biotherapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude